Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;25(8):1505-11.
doi: 10.1007/s00467-010-1536-8. Epub 2010 May 27.

Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease

Affiliations

Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease

Lauren J Becton et al. Pediatr Nephrol. 2010 Aug.

Abstract

Sickle cell disease (SCD) is associated with a large spectrum of renal abnormalities, one of which, microalbuminuria/proteinuria (MA/P), is a known predictor of end-stage renal disease. We studied 90 children with SCD (57% male; mean age 11.4 +/- 5.2 years) to determine the prevalence and examine clinical correlates of MA/P. The average of two spot urine microalbumin-to-creatinine samples obtained 6 months apart was recorded. Medical records were reviewed for demographic and biochemical data. Medication use, resting office blood pressures (BP), vaso-occlusive pain crises (VOC), and monthly transfusions were recorded. Fourteen children (15.5%) had MA/P. Hemoglobin (Hb) levels were significantly lower in the children with MA than in those without MA/P (8.8 +/- 1.1 vs. 9.8 +/- 1.4 g/dL, respectively) and were significantly correlated with MA (rho = 0.24, p = 0.03). Children with MA were more likely to have abnormal BP (p = 0.058), with 5/14 being hypertensive or pre-hypertensive. In a multivariate logistic regression model of MA, both Hb and BP classification remained in the final model. MA is a simple screening biomarker of early kidney injury in children with SCD. Larger studies to evaluate predictive factors of MA and the relationship to BP are needed.

PubMed Disclaimer

References

    1. Ann Intern Med. 1991 Oct 15;115(8):614-20 - PubMed
    1. J Pediatr Hematol Oncol. 2005 Mar;27(3):158-61 - PubMed
    1. J Pediatr. 2000 Jun;136(6):749-53 - PubMed
    1. Kidney Int. 1988 Oct;34(4):500-6 - PubMed
    1. Indian J Pediatr. 2003 Apr;70(4):307-9 - PubMed

MeSH terms